An ex Vivo Assay for Estimating the Antiviral State of Hepatocytes
スポンサーリンク
概要
- 論文の詳細を見る
An ex vivo antiviral assay was established which uses hepatocytes from mice given recombinant mouse interferon-β (rmIFN-β). Assay results were compared with results obtained with a 2', 5'-oligoadenylate synthetase (2-5AS) assay. rmIFN-β was intraperitoneally administered to C3H mice and the antiviral state of their liver parenchymal cells was evaluated in an in vitro cytopathic effect assay. In this assay, cells are infected with vesicular stomatitis virus (VSV) and surviving cells are determined colorimetrically. The antiviral state was measured as the resistance of hepatocytes to VSV infection with increasing doses of rmIFN-β. The antiviral state correlated well with the dose-dependent increase in hepatic 2-5AS activity. This good correlation suggests that induction of 2-5AS mediates the antiviral action of interferon in liver tissue. This ex vivo assay could be a useful tool for estimating the ability of hepatocytes to resist hepatitis virus infection.
- 社団法人日本薬学会の論文
- 1994-12-15
著者
-
佐藤 純
Dds Research Laboratories Takeda Chemical Industries Ltd.
-
岩佐 進
DDS Research Laboratories Pharmaceutical Research Division, Takeda Chemical Industries, Ltd.
-
小川 泰亮
DDS Research Laboratories Pharmaceutical Research Division, Takeda Chemical Industries, Ltd.
-
渡辺 明子
DDS Research Laboratories, Takeda Chemical Industries, Ltd.
-
黒川 智文
DDS Research Laboratories, Takeda Chemical Industries, Ltd.
-
小川 泰亮
武田薬品工業(株)dds研究所
-
小川 泰亮
武田薬品工業株式会社dds研究所
-
岩佐 進
武田薬品工業・DDS研究所
-
黒川 智文
Dds Research Laboratories Takeda Chemical Industries Ltd.
-
渡辺 明子
Dds Research Laboratories Takeda Chemical Industries Ltd.
関連論文
- 徐放性マイクロカプセル製剤からの薬物放出性解析
- LHRH アゴニスト注射用マイクロカプセル徐放剤からの薬物放出in vitro評価系
- A New Technique to Efficiently Entrap Leuprolide Acetate into Microcapsules of Polylactic Acid or Copoly(Lactic/Glycolic) Acid
- Enhancement of the Anti-tumor Activity of Recombinant Interleukin-2 (rIL-2) by Immunocomplexing with an F (ab')_2 Fragment of Murine Monoclonal Antibody against rIL-2
- Pharmacokinetic Alteration in Rats of Recombinant Interleukin-2 (rIL-2) by Immunocomplexing with a Monoclonal Antibody against rIL-2
- 酢酸リュープロレリン徐放性注射剤
- ポリ乳酸/グリコール酸を用いた甲状腺刺激ホルモン放出ホルモン徐放性マイクロスフェア
- In Vivo Release Profiles of Leuprolide Acetate from Microcapsules Prepared with Polylactic Acids or Copoly(Lactic/Glycolic) Acids and in Vivo Degradation of These Polymers
- Controlled-Release of Leuprolide Acetate from Polylactic Acid or Copoly(Lactic/Glycolic) Acid Microcapsules : Influence of Molecular Weight and Copolymer Ratio of Polymer
- An ex Vivo Assay for Estimating the Antiviral State of Hepatocytes
- 生体内分解性高分子を用いた黄体形成ホルモン放出ホルモン誘導体の放出制御に関する研究
- 生体内分解性高分子を利用した水溶性ペプチドのマイクロカプセル形放出制御製剤
- Interaction of Methyl p-Hydroxybenzoate with Polyoxyethylene Dodecyl Ethers
- Ultrafiltration Method for Measuring Free Preservatives in Aqueous Phase of Oil-in-Water Emulsions
- ホルモン依存性疾患に有用な治療剤:リュ-プリン 長期徐放マイクロカプセルの設計
- 消化管粘膜付着性細粒剤の有効性評価におけるヒトと実験動物との比較
- 1ヵ月にわたり薬物を徐放するマイクロカプセル,リュープリン【○!R】の開発
- 黄体形成ホルモン放出ホルモンアゴニストのDDS
- 第1回DDS研究会
- 安定性研究のための人工気象室
- A Sensitive ELISA for the Characterization of Two Forms of Circulating Intercellular Adhesion Molecule-1 in Human Plasma
- GnRHアゴニスト--酢酸リュ-プロレリン徐放性注射剤の効果
- アスコルビン酸誘導体, disodium 2-O-octadecyl-5, 6-di-O-sulfoascorbate (CV-11464) の水溶液中でのマルトシル-β-シクロデキストリンによる安定化
- アスコルビン酸誘導体, disodium 2-O-octadecyl-5, 6-di-O-sulfoascorbate (CV-11464) の安定性およびその分解機構
- Antagonism of the Human Thromboxane A_2 Receptor by an Anti-asthmatic Agent AA-2414